Decoding the glycan shield: Immune recognition and response to the HIV-1 envelope trimer.

Area of Science:

• * Immunology
• * Virology
• * Vaccinology

Background:

• * The HIV-1 envelope glycoprotein (Env) trimer is crucial for viral entry and a primary target for neutralizing antibodies.
• * Env is heavily glycosylated, with up to 90 N-linked glycosylation sites shielding the protein from immune surveillance.
• * While Env glycosylation's role in B cell recognition is known, its impact on T cell responses is less understood.

Purpose of the Study:

• * To review adaptive immune responses to HIV Env, focusing on glycosylation's dual role.
• * To examine how glycosylation constrains B cell recognition while aiding T cell responses.
• * To inform future HIV vaccine development strategies for robust protection.

Main Methods:

• * Literature review of adaptive immune responses to HIV Env.
• * Analysis of the impact of N-linked glycosylation on Env structure and immune recognition.
• * Examination of Env glycopeptides as potential T cell epitopes.

Main Results:

• * Env glycosylation simultaneously hinders B cell recognition by broadly neutralizing antibodies (bnAbs).
• * Glycosylation also plays a role in antigen processing and shaping T cell-mediated immunity.
• * Env-derived glycopeptides may function as unconventional CD4+ T cell epitopes.

Conclusions:

• * Env glycosylation presents a complex challenge and opportunity for HIV vaccine design.
• * Strategies must account for glycosylation's influence on both B and T cell immunity.
• * Further research into glycopeptide epitopes can guide the development of next-generation HIV vaccines.